cGxP.wire https://validator.w3.org/feed/docs/rss2.html FDA Approves Tregzi to Prevent Chronic GVHD in Blood Cancer Newron Reports FDA Progress on Evenamide Phase 3 ENIGMA-TRS 2 Trial Orca Bio Wins FDA Approval for TREGZI Cell Therapy NKGen Biotech to Highlight Troculeucel Alzheimer’s Program at BIOCHINA Forum Insilico Secures Up to $600M Takeda AI Discovery Deal Telum Therapeutics Raises €18M Series A for AMR Program Oliva Therapeutics Launches Amerithroid for Hypothyroidism Abbisko and AstraZeneca Advance Oral PD-L1 Therapy for NSCLC GENFIT Secures U.S. Medicare Coverage for NASHnext Diagnostic Test AOB Pharma Partners Biorasi for Phase 2b Acne Trial Northwest Biotherapeutics to Present DCVax-L Survival Analysis at BNOS 2026 Arima Genomics Partners with Active Motif for Hi-C Research Distribution Mobia Medical Secures CMS Proposed 2027 Reimbursement for Vivistim Rosalind Franklin University Unveils New Infertility Research Telix Secures FDA Alignment to Advance ProstACT Phase 3 Trial Otsuka Advances VOYXACT Toward Traditional FDA Approval with Phase 3 Success Co-Diagnostics Completes Validation for FDA 510(k) Submission Hansa Biopharma Completes €115M Idefirix Licensing Deal Arcus Biosciences Publishes Casdatifan Kidney Cancer Data Multitude Therapeutics Reports Positive AMT-676 Phase I Data 92Bio Doses First Patient in Phase 1 Trial of NTB-928 for Platinum-Resistant Ovarian Cancer Endologix Reports 3-Year DETOUR2 Trial Success in PAD Partner Therapeutics Reports JCO Results for BIZENGRI Neurocrine Initiates Phase 2 Trial of Crinecerfont in Children Under 4 with Classic CAH Vertex Secures FDA Approval to Expand CASGEVY Use in Young Children Envoy Medical Submits First Module of FDA PMA Application for Breakthrough Hearing Implant Partillion Bioscience Unveils New Framework for Cell Biology Roche’s Divarasib Beats Approved KRAS Therapies in Phase III Trial Advita Ortho Launches Next-Generation Knee Platform in Japan Francis Medical Publishes VAPOR 2 Trial Results in The Journal of Urology Novartis Wins EU Approval for Itvisma® in Broad SMA Care RefleXion Submits FDA 510(k) for Anchor Point Tracking Headlands Research Expands California Footprint with Clinical Trials Research Acquisition BeOne Announces Positive Phase 3 Results for BRUKINSA Laplace Gains FDA IDE for TRIUMPH TTVR Pivotal Trial Serenity Medical Receives FDA Breakthrough Device Designation for Shepherd Stent™ System Cumulus Advances Alzheimer’s Research with NeuLogiq Platform Apotex Secures Health Canada Approval for SEVMIA™ Contineum Therapeutics Publishes PIPE-791 Discovery Study STARMED Becomes First to Gain FDA Clearance for Thyroid RFA Kowa Gains FDA Breakthrough Status for K-808 in PBC Myriad Genetics Prolaris Study Validates Prostate Risk Test Saluda Medical Wins FDA Approval for CAP24 Paddle Lead Junshi Biosciences Expands Roconkibart Through Fosun Alliance HUTCHMED Wins NMPA Approval for ORPATHYS® in Gastric Cancer Ipsen Acquires Memo Therapeutics to Expand Rare Disease Pipeline Revolution Medicines Reports Promising Phase 1/2 Zoldonrasib Combination Data in Metastatic Pancreatic Cancer Samsung Bioepis Relaunches BYOOVIZ with Harrow in the U.S. ARTAN Bio Secures $1M Seed Round for tRNA Platform MiDOG Launches First NGS Parasite Test for Veterinary Care